Stock search

Ticker or company name

Compare stocks

Market: US

  • CORCencora
  • CAHCardinal Health
  • BSXBoston Scientific

Add stock

Ticker or company

Summary

COR
Cencora
$356,94Down −0,58%
Year: Down −4%
83/100Best scoreRatio would consider buying
Open stock page
CAH
Cardinal Health
$283,85Up +0,98%
Year: Up +36%

Not enough data for a score

Open stock page
BSX
Boston Scientific
$43,69Down −1,47%
Year: Down −58%
83/100Best scoreRatio would consider buying
Open stock page

Verdict

COR has the best score (83). CAH grows revenue the fastest. BSX is the cheapest by forward P/E. BSX has the lowest debt load. BSX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckCOR6 ✓ 3 — 0 ✕CAH1 ✓ 0 — 2 ✕BSX6 ✓ 3 — 0 ✕
P/E vs its history19,735,718,4
P/E vs industry19,735,718,4
Forward P/E16,819,214,0
Revenue growth, YoY+5,1%n/a—+8,9%
EPS growth, YoY+38,3%n/a—+26,2%
Net margin0,8%n/a—16,6%
Net debt / EBITDA2,4n/a—−0,1
Free cash flow$4,06 bnn/a—$3,33 bn
Share count over a year−0,7%n/a—−2,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCORTTMCAHTTMBSXTTMIndustry medianTTM
P/E TTM ↓19,7Worst: 35,7Best: 18,425,1
Forward P/E ↓16,8Worst: 19,2Best: 14,016,2
PEG ↓2,4Worst: 3,1Best: 0,72,2
P/S TTM ↓Best: 0,20,3Worst: 3,12,2
EV/EBITDA ↓Best: 15,1Worst: 23,215,617,3
P/FCF ↓Best: 10,913,3Worst: 19,319,5

Price, %

  • CORn/a
  • CAHn/a
  • BSXn/a

Returns

Best WorstNo mark — in between

PeriodCORCAHBSX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CORCAHBSX
Share of “buy”70%Best: 86%Worst: 65%
Beat the forecastWorst: 3 of 4Best: 4 of 4Best: 4 of 4
Average “surprise”Worst: +0,1%Best: +9,5%+1,5%
Insiders over 12 monthssales $13,1 msales $61,6 msales $6,76 m

Details are on each stock page.